Abstract
Mitotic counts in the World Health Organization (WHO) grading system have narrow cutoff values. True mitotic figures, however, are not always distinguishable from apoptotic bodies and darkly stained nuclei, complicating the ability of the WHO grading system to diagnose well-differentiated neuroendocrine tumors (NETs). The mitosis-specific marker phosphohistone H3 (PHH3) can identify true mitoses and grade tumors reliably. The aim of this study was to investigate the correspondence of tumor grades, as determined by PHH3 mitotic index (MI) and mitotic counts according to WHO criteria, and to determine the clinically relevant cutoffs of PHH3 MI in rectal and nonrectal gastrointestinal NETs. Mitotic counts correlated with both the Ki-67 labeling index and PHH3 MI, but the correlation with PHH3 MI was slightly higher. The PHH3 MI cutoff ≥4 correlated most closely with original WHO grades for both rectal NETs. A PHH3 MI cutoff ≥4, which could distinguish between G1 and G2 tumors, was associated with disease-free survival in patients with rectal NETs, whereas that cutoff value showed marginal significance for overall survival in patient with rectal NETs. In conclusion, the use of PHH3 ≥4 correlated most closely with original WHO grades.
References
Jan 10, 1998·Chromosoma·M J HendzelC D Allis
Sep 12, 1998·The Journal of Biological Chemistry·M J HendzelJ P Th'ng
May 29, 2008·Cancer·Ulrich-Frank PapeBertram Wiedenmann
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoDouglas B Evans
Jan 9, 2010·Journal of Gastroenterology·Tetsuhide ItoMasayuki Imamura
Apr 17, 2010·International Journal of Colorectal Disease·Sang Nam YoonJin Cheon Kim
Aug 13, 2010·Endocrine-related Cancer·Martin B NiederleBruno Niederle
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Ben LawrenceIrvin M Modlin
Jan 21, 2012·Neuroendocrinology·Martyn CaplinUNKNOWN Barcelona Consensus Conference participants
Oct 24, 2012·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Mee-Yon ChoSei Jin Chang
Nov 22, 2012·Journal of Gastroenterology and Hepatology·Rajneesh Kumar Singh, Govindaraju Parthasarathy
Apr 13, 2013·British Journal of Cancer·M S KhanT Meyer
Jul 9, 2014·BMC Endocrine Disorders·Xianbin ZhangPeng Gong
Oct 25, 2014·Gastroenterology Report·James Wei Tatt TohLes Bokey
Oct 30, 2014·The American Journal of Surgical Pathology·Sarah M VossZhaohai Yang
Feb 20, 2015·American Journal of Clinical Pathology·Ahmad AlkhasawnehLizette Vila Duckworth
Mar 31, 2015·Journal of Pathology and Translational Medicine·Yooju ShinKyoung-Mee Kim
Jul 19, 2015·Journal of Clinical Pathology·R K VarugheseS H Torp
Aug 19, 2015·Journal of the American Academy of Dermatology·Karl OttmannChristina Mitteldorf
Jan 6, 2016·Neuroendocrinology·Dermot O'TooleMartyn Caplin
Mar 30, 2016·Annals of Surgical Oncology·Vincenzo VillaniCristina R Ferrone
Nov 30, 2016·World Journal of Gastroenterology : WJG·Mi Jung KwonEun Sook Nam
Feb 19, 2017·Pathology, Research and Practice·Mi Jung KwonHye Kyung Lee
May 30, 2017·Pathology, Research and Practice·Mi Jung KwonJi-Young Choe
Jun 14, 2017·BioMed Research International·Mi Jung KwonYoung-Soo Rho